SEC Form 4 · accession 0000899243-16-029695
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher P Kiritsy
Director
Period of report
Sep 20, 2016
Accepted (ET)
Sep 22, 2016 · 10:44 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.59 | Sep 20, 2016 | A | 30,000 | A | — | Sep 20, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The stock option will vest in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director.